Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer

Inhibition of LPS-stimulated ecto-adenosine deaminase attenuates endothelial cell activation

(2019) Barbara Kutryb-Zajac et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Impaired l-arginine metabolism marks endothelial dysfunction in CD73-deficient mice

(2019) P. Mierzejewska et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Analysis of Deficiency of Adenosine Deaminase 2 Pathogenesis Based on Single Cell RNA Sequencing of Monocytes

(2019) Naoki Watanabe et al.   BLOOD

Effects Of Adenosine On Apoptosis Of Ovarian Cancer A2780 Cells Via ROS And Caspase Pathways

(2019) Bing Xia et al.   OncoTargets and Therapy

Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents

(2018) Matteo Santoni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Tumor associated macrophages in gynecologic cancers

(2018) Venkatesh Krishnan et al.   GYNECOLOGIC ONCOLOGY

Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms

(2018) Barbara Kutryb-Zajac et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer

(2017) Muhammad Tariq et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Application of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis

(2017) Mariola Olkowicz et al.   JOURNAL OF CHROMATOGRAPHY A

The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens

(2017) Laura Díaz-Alvarez et al.   MEDIATORS OF INFLAMMATION

Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression

(2017) Changbin Zhu et al.   NEURO-ONCOLOGY

More T Cells versus Better T Cells in Patients with Breast Cancer

(2017) Daniel E. Speiser et al.   Cancer Discovery

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer

(2017) Guilhem Bousquet et al.   Oncotarget

Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition

(2016) Barbara Kutryb-Zajac et al.   CARDIOVASCULAR RESEARCH

Monogenic polyarteritis: the lesson of ADA2 deficiency

(2016) Roberta Caorsi et al.   Pediatric Rheumatology

Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents

(2016) Beverly L. Falcon et al.   PHARMACOLOGY & THERAPEUTICS

Anticancer effect of adenosine on gastric cancerviadiverse signaling pathways

(2015) Ayako Tsuchiya   WORLD JOURNAL OF GASTROENTEROLOGY

Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

(2014) Qing Zhou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer

(2013) R. Joseph Bender et al.   PLoS One

Purines, Purinergic Receptors, and Cancer

(2012) F. Di Virgilio   CANCER RESEARCH

Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders

(2012) Luca Antonioli et al.   CURRENT DRUG TARGETS

Diagnostic Value of Adenosine Deaminase Activity in Benign and Malignant Breast Tumors

(2010) Mahmoud Aghaei et al.   ARCHIVES OF MEDICAL RESEARCH

Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages

(2010) A. V. Zavialov et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Extracellular adenosine triphosphate and adenosine in cancer

(2010) J Stagg et al.   ONCOGENE

Nucleoside Transporter Proteins

(2009) Miriam Molina-Arcas et al.   Current Vascular Pharmacology